| 1Reduced Interferon |
|---|
| 2Interferon |
Analyte not found
Applications
Interferon Alpha digests reduced & non-red on Jupiter 3u C18
18072
Separation Mode: Reversed Phase
Reversed Phase
C18
HPLC
Pharmaceutical/Biopharmaceutical
Life Science
Clinical Research
Therapeutic / Clinical
Analytes
Details
LC Conditions (App ID: 18072)
Column: | ||||||||||||||||
Brand Name: | ||||||||||||||||
Part No: | ||||||||||||||||
Phase Name: C18 | ||||||||||||||||
Elution Type: Gradient | ||||||||||||||||
Mobile Phase: A: 0.1% TFA and 2% Acetonitrile in Water B: 0.085% TFA, 90% Acetonitrile in Water | ||||||||||||||||
Gradient Profile:
| ||||||||||||||||
Flow Rate: 0.3 mL/min | ||||||||||||||||
Temperature: 25°C | ||||||||||||||||
Detection: UV-Vis Abs.-Diode Array (PDA) @ 214 nm (25°C) | ||||||||||||||||
Sample Note: Application Focus: Using peptide mapping with Jupiter 300 3u C18 to identify disulfide bonds
Peptide mapping using different proteases is a good analytical method to screen PTMs of therapeutic proteins and is shown on Jupiter 300 3u C18 for a biogeneric alpha interferon. Interferon-alpha is a 19.2 kDa protein containing two disulfide bonds (cys1-cys98; cys29-cys138) and was tryptic digested (1:20 E/S ratio, 18 hrs at 37C) and then half of the digest was reduced with DTT (3 mM DTT at 45°C for 30 min). Both native and reduced tryptic digests injected on the Jupiter 300 C18 columns and overlaid. App ID 18072 shows that peptides retention time shifting due to disulphide bonds breakage after reduction reaction. Such shifts are clearly observed in the peak distribution at different retention times of the trypsin digested Interferon- alpha(lower chromatogram) and Interferon-alpha digested and reduced (upper chromatogram). Such shifts are indicative of a disulfide containing peptide and are easily verified by mass spectrometry. The high resolution that the Jupiter 300 3u C18 column delivers makes it an excellent choice for peptide mapping. |
Order Items Used in This Application
00F-4263-B0
Jupiter 3 µm C18 300 Å, LC Column 150 x 2 mm, Ea
Qty:
Similar Applications
search
Reduced Interferon
No Data
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
CONNECT WITH US
